Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Foresite Capital Opportunity Management V, Llc > Profile

Instuitional Investor - Foresite Capital Opportunity Management V, Llc

Fund Profile
Filing Period:
Fund Name: Foresite Capital Opportunity Management V, Llc
Portfolio Value $33,307,000
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Pardes Biosciences Inc
 5,227,307 $9,671,000 29.03%
2.
Theseus Pharmaceuticals Inc.
 THRX 959,275 $5,564,000 16.7%
3.
Gemini Therapeutics Inc.
 GMTX 243,512.5 $3,994,000 11.99%
4.
Compass Therapeutics Inc.
 CMPX 1,554,250 $3,544,000 10.64%
5.
Kinnate Biopharma Inc.
 KNTE 291,667 $3,485,000 10.46%
Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)